Weight loss jab users warned of Christmas vomiting risk
A clinical pharmacist warns festive overindulgence could cause severe sickness for millions on weight loss injections. Read expert tips to stay safe this Christmas.
Category : Search result: GLP1 receptor agonists
GLP-1 Weight Loss Drugs Linked to Suicidal Thoughts
Australia's TGA issues safety warning after 85 reports link Ozempic, Mounjaro & similar drugs to suicidal ideation and self-harm. Patients urged to monitor mental health.
New Weight Loss Pill Shows 9.6% Reduction in Trial
A new daily pill from Lilly promises significant weight loss and blood sugar control, offering a needle-free alternative to injections. Could this revolutionise obesity treatment in the UK?
Weight Loss Jabs Cause Spike in Haemorrhoids
A leading doctor reveals a 41% rise in haemorrhoid cases linked to popular weight loss injections like Ozempic and Mounjaro. Learn about the side effects and expert advice.
Weight-loss jabs may hide cancer in medical scans
Groundbreaking research reveals GLP-1 agonists like Ozempic and Wegovy may cause misleading results on CT and PET scans, potentially hiding cancers and leading to dangerous misdiagnoses.
Weight loss injections may relieve asthma symptoms
New research suggests that GLP-1 receptor agonists, commonly used for weight loss, may also improve asthma symptoms in obese individuals. Discover the potential dual benefits of these medications.
Page 1 of 1